Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US0042251084
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000BHG9K0
ACAD
ACADIA Pharmaceuticals Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
ACADIA Pharmaceuticals Inc
ISIN
US0042251084
TICKER
ACAD
MIC
XNAS
REUTERS
ACAD.OQ
BLOOMBERG
ACAD US
Do., 17.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 17, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021.If you suffered a loss, contact us at the link below. There is no cost or...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Do., 17.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 17, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Do., 17.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 17, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) alleging that the Company violated federal securities laws.Class Period: June 15, 2020 and April 4, 2021Lead Plaintiff Deadline: June 18, 2021Learn m...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mi., 16.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 16, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mi., 16.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Di., 15.06.2021       ACADIA Pharmaceuticals
US0042251084

San Francisco, California--(Newsfile Corp. - June 15, 2021) -  Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff Deadline: June 18, 2021Visit: www.hbsslaw.com/investor-fraud/ACADContact An Attorney Now: ACAD@hbssl...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Di., 15.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Di., 15.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 15, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ACADIA Pharmaceuticals Inc. ("ACADIA" or "the Company") (NASDAQ: ACAD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired ACADIA securities betwee...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Di., 15.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 14, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) alleging that the Company violated federal securities laws.Class Period: June 15, 2020 and April 4, 2021Lead Plaintiff Deadline: June 18, 2021Learn...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mo., 14.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 14, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 14.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
So., 13.06.2021       ACADIA Pharmaceuticals
US0042251084

San Francisco, California--(Newsfile Corp. - June 13, 2021) -  Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff Deadline: June 18, 2021Visit: www.hbsslaw.com/investor-fraud/ACADContact An Attorney Now: ACAD@hbssl...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
So., 13.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 12, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. ("Acadia" or the "Company")(NASDAQ: ACAD) and certain of its officers. The class action, filed in the United States District Court for the Southern District of California, and docketed under...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Fr., 11.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) ("Acadia" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Do., 10.06.2021       ACADIA Pharmaceuticals
US0042251084

San Francisco, California--(Newsfile Corp. - June 10, 2021) -  Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff Deadline: June 18, 2021Visit: www.hbsslaw.com/investor-fraud/ACADContact An Attorney Now: ACAD@hbssl...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Do., 10.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mi., 09.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 9, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mi., 09.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 8, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class actio...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mi., 09.06.2021       ACADIA Pharmaceuticals
US0042251084

San Francisco, California--(Newsfile Corp. - June 8, 2021) -  Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff Deadline: June 18, 2021Visit: www.hbsslaw.com/investor-fraud/ACADContact An Attorney Now: ACAD@hbssla...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Di., 08.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 8, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021.If you suffered a loss, contact us at the link below. There is no cost or...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 08.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 8, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Di., 08.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 8, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) alleging that the Company violated federal securities laws.Class Period: June 15, 2020 and April 4, 2021Lead Plaintiff Deadline: June 18, 2021Learn mo...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mo., 07.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 7, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mo., 07.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 7, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
So., 06.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 5, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ: ACAD) and certain of its officers. The class action, filed in the United States District Court for the Southern District of California, and docketed under...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Fr., 04.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 4, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021, inclusive (the "Class Period"). A class action lawsuit has alre...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Fr., 04.06.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - June 3, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class actio...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Do., 03.06.2021       ACADIA Pharmaceuticals
US0042251084

San Francisco, California--(Newsfile Corp. - June 3, 2021) -  Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff Deadline: June 18, 2021Visit: www.hbsslaw.com/investor-fraud/ACADContact An Attorney Now: ACAD@hbssla...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Do., 03.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mi., 02.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Di., 01.06.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - June 1, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mo., 31.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 31, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on the behalf of investors who purchased Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021.If you suffered a loss, contact us at the link below. There is no cost or obli...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mo., 31.05.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - May 31, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mo., 31.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 31, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) alleging that the Company violated federal securities laws.Class Period: June 15, 2020 and April 4, 2021Lead Plaintiff Deadline: June 18, 2021Learn mo...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
So., 30.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 30, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class action...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
So., 30.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 29, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. ("Acadia" or the "Company")(NASDAQ: ACAD) and certain of its officers. The class action, filed in the United States District Court for the Southern District of California, and docketed under...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Fr., 28.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 28, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Fr., 28.05.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - May 28, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Do., 27.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 27, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class action...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Do., 27.05.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - May 27, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Di., 25.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class action...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mo., 24.05.2021       ACADIA Pharmaceuticals
US0042251084

San Francisco, California--(Newsfile Corp. - May 24, 2021) -  Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff Deadline: June 18, 2021Visit: www.hbsslaw.com/investor-fraud/ACADContact An Attorney Now: ACAD@hbssla...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
So., 23.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 22, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ: ACAD) and certain of its officers. The class action, filed in the United States District Court for the Southern District of California, and docketed under...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Fr., 21.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 21, 2021) -  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) alleging that the Company violated federal securities laws.Class Period: June 15, 2020 and April 4, 2021Lead Plaintiff Deadline: June 18, 2021Le...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Fr., 21.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 20, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Fr., 21.05.2021       ACADIA Pharmaceuticals
US0042251084

San Francisco, California--(Newsfile Corp. - May 20, 2021) -  Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff Deadline: June 18, 2021Visit: www.hbsslaw.com/investor-fraud/ACADContact An Attorney Now: ACAD@hbssla...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mo., 17.05.2021       ACADIA Pharmaceuticals
US0042251084

San Francisco, California--(Newsfile Corp. - May 17, 2021) - Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now.Class Period: June 15, 2020 - Apr. 4, 2021Lead Plaintiff Deadline: June 18, 2021Visit: www.hbsslaw.com/investor-fraud/ACADContact An Attorney Now: ACAD@hbsslaw.com844...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Do., 13.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 13, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class action...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mi., 12.05.2021       ACADIA Pharmaceuticals
US0042251084

Los Angeles, California--(Newsfile Corp. - May 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ACADIA Pharmaceuticals Inc. ("Acadia" or "the Company") (NASDAQ: ACAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink
Mi., 12.05.2021       ACADIA Pharmaceuticals
US0042251084

New York, New York--(Newsfile Corp. - May 11, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ: ACAD) between June 15, 2020 and April 4, 2021. You are hereby notified that a securities class action...
Zur Nachricht
ACADIA Pharmaceuticals
Charts & Research Termsheets Terminal
Permalink